Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Gerratana L, Pierga JY, Reuben JM, Davis AA, Wehbe FH, Dirix L, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, Bonotto M, Fernandez de Lascoiti A, De Mattos-Arruda L, Ignatiadis M, Sandri MT, Generali D, De Angelis C, Dawson SJ, Janni W, Carañana V, Riethdorf S, Solomayer EF, Puglisi F, Giuliano M, Pantel K, Bidard FC, Cristofanilli M. Gerratana L, et al. Among authors: cristofanilli m. Oncologist. 2022 Jul 5;27(7):e561-e570. doi: 10.1093/oncolo/oyac045. Oncologist. 2022. PMID: 35278078 Free PMC article.
Update on the management of inflammatory breast cancer.
Cristofanilli M, Buzdar AU, Hortobágyi GN. Cristofanilli M, et al. Oncologist. 2003;8(2):141-8. doi: 10.1634/theoncologist.8-2-141. Oncologist. 2003. PMID: 12697939 Free article. Review.
p53 expression as a prognostic marker in inflammatory breast cancer.
Gonzalez-Angulo AM, Sneige N, Buzdar AU, Valero V, Kau SW, Broglio K, Yamamura Y, Hortobagyi GN, Cristofanilli M. Gonzalez-Angulo AM, et al. Among authors: cristofanilli m. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6215-21. doi: 10.1158/1078-0432.CCR-04-0202. Clin Cancer Res. 2004. PMID: 15448010
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.
Yang CH, Gonzalez-Angulo AM, Reuben JM, Booser DJ, Pusztai L, Krishnamurthy S, Esseltine D, Stec J, Broglio KR, Islam R, Hortobagyi GN, Cristofanilli M. Yang CH, et al. Among authors: cristofanilli m. Ann Oncol. 2006 May;17(5):813-7. doi: 10.1093/annonc/mdj131. Epub 2006 Jan 10. Ann Oncol. 2006. PMID: 16403809 Free article. Clinical Trial.
454 results